Establishment Labs (NASDAQ:ESTA) Trading Up 6.8% – What’s Next?

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s stock price shot up 6.8% during mid-day trading on Wednesday . The stock traded as high as $40.72 and last traded at $40.07. 338,672 shares changed hands during mid-day trading, a decline of 12% from the average session volume of 386,367 shares. The stock had previously closed at $37.52.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. BTIG Research upped their price objective on Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a report on Monday, October 14th. Stephens reaffirmed an “overweight” rating and issued a $68.00 price target on shares of Establishment Labs in a research note on Wednesday, August 7th. Citigroup increased their price target on shares of Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Establishment Labs from $61.00 to $50.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Establishment Labs currently has an average rating of “Moderate Buy” and a consensus price target of $60.60.

Establishment Labs Stock Up 1.0 %

The company has a market capitalization of $1.21 billion, a P/E ratio of -16.52 and a beta of 1.20. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The firm has a fifty day simple moving average of $42.97 and a 200-day simple moving average of $45.31.

Institutional Trading of Establishment Labs

A number of large investors have recently bought and sold shares of ESTA. Hood River Capital Management LLC bought a new position in Establishment Labs in the second quarter valued at approximately $43,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Establishment Labs during the third quarter worth $127,000. Nkcfo LLC bought a new stake in Establishment Labs in the 2nd quarter valued at $227,000. SG Americas Securities LLC acquired a new position in Establishment Labs in the 2nd quarter worth $303,000. Finally, Black Swift Group LLC bought a new position in Establishment Labs during the 3rd quarter worth about $312,000. 72.91% of the stock is owned by institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.